Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunct CellCept to reduce corticosteroids in myasthenia gravis
2004-000596-34Phase 3Completed
- Sponsor
- Roche
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myasthenia gravis (MG) comparing CellCept + prednisone with Placebo + prednisone (2 arms). Primary endpoint: Responder status proportion. Started May 2005; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on 2004-000596-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000596-34.